- Home
- CTXR vs RBNE Comparison
CTXR vs RBNE Comparison
Compare CTXR & RBNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTXR | RBNE |
|---|---|---|
| Founded | 2007 | 2024 |
| Country | United States | Cyprus |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6M | 15.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CTXR | RBNE |
|---|---|---|
| Price | $0.83 | $4.41 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 338.1K | 331.5K |
| Earning Date | 02-13-2026 | 02-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $6,869,234.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $147.57 | N/A |
| P/E Ratio | ★ N/A | $48.26 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.63 | $2.78 |
| 52 Week High | $3.35 | $123.25 |
Technical Indicators
Market Signals| Indicator | CTXR | RBNE |
|---|---|---|
| Relative Strength Index (RSI) | 38.57 | 76.66 |
| Support Level | $0.79 | $3.60 |
| Resistance Level | $0.85 | $4.10 |
| Average True Range (ATR) | 0.05 | 0.46 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 34.76 | 88.08 |
Price Performance
Historical ComparisonAbout CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.
About RBNE Robin Energy Ltd.
Robin Energy Ltd operates a tanker vessel that engages in the transportation of refined petroleum products using its Handysize product tanker.